November 26, 2025
The U.S. behavioral health market is anticipated to grow from USD 101.84 billion in 2026 to USD 159.35 billion...
Read MoreNovember 13, 2025
The blood pressure measuring devices market is expected to see growth from USD 2.08 billion in 2026 to USD 4.5...
Read MoreNovember 01, 2025
The U.S. digital health market size is forecast to increase from USD 98.69 billion in 2026 to USD 238.65 billi...
Read MoreNovember 13, 2025
The hospital services market is predicted to grow from USD 13.19 trillion in 2026 to USD 28.99 trillion by 203...
Read MoreNovember 01, 2025
Based on market forecasts, the cell and gene therapy CDMO sector will expand from USD 6.41 billion in 2024 to USD 75.32 billion by 2034, experiencing a CAGR of 27.94%. In 2024, North America led the cell and gene therapy CDMO market with a 41% share, while Asia Pacific is set for the fastest growth. Oncology dominated by indication, but rare diseas...
November 01, 2025
The diabetic retinopathy industry is projected to rise from USD 9.52 billion in 2024 to USD 17.82 billion by 2034, reflecting a CAGR of 6.47% over the next decade. In 2024, North America led the diabetic retinopathy market, while Asia-Pacific is set for strong growth. Non-proliferative diabetic retinopathy held the largest share, but proliferative ...
November 01, 2025
According to market projections, the topical drugs CDMO sector is expected to grow from USD 46.32 billion in 2024 to USD 136.71 billion by 2034, reflecting a CAGR of 11.43%. In 2024, Asia Pacific led the topical drugs CDMO market, with Latin America poised for strong growth. Semi-solid formulations and contract manufacturing dominated, while liquid...
November 01, 2025
According to market projections, the Germany iron deficiency anemia therapy sector is expected to grow from USD 401.27 million in 2024 to USD 830.14 million by 2034, reflecting a CAGR of 7.54%. Iron deficiency anemia occurs when the body lacks enough red blood cells due to low iron. Causes include blood loss, heavy periods, pregnancy, and some medi...
November 01, 2025
Market insights predict the global medical device testing industry will increase from USD 9.84 billion in 2024 to USD 24.32 billion by 2034, achieving a CAGR of 9.47%. In 2024, Asia-Pacific led the global medical device testing market, while North America is set for the fastest growth ahead. Biocompatibility tests dominated by service, with chemist...
November 01, 2025
Forecasts suggest that the small molecule CDMO market will expand from USD 72.81 billion in 2024 to USD 145.12 billion by 2034, with a CAGR of 7.14% during this period. In 2024, North America led the small molecule CDMO market, with APIs holding the largest product share and innovators dominating by drug type. Oncology was the top application. Look...
November 01, 2025
Based on market forecasts, the cough assist devices sector will expand from USD 275.99 million in 2024 to USD 547.99 million by 2034, experiencing a CAGR of 7.24%. In 2024, North America led the global cough assist devices market, while Asia-Pacific is set for the fastest growth. Automatic devices dominated by product type, with mouthpieces le...
November 01, 2025
According to market projections, the pharmacy automation sector is expected to grow from USD 6.35 billion in 2024 to USD 16.65 billion by 2034, reflecting a CAGR of 10.12%. In 2024, North America led the pharmacy automation market with a 42% share, while Asia-Pacific is set for the fastest growth. Dispensing systems dominated by product, with pill ...
November 01, 2025
Based on market forecasts, the oligonucleotide CDMO sector will expand from USD 2.55 billion in 2024 to USD 18.37 billion by 2034, experiencing a CAGR of 21.83%. In 2024, North America led the oligonucleotide CDMO market, with Asia Pacific poised for the fastest growth. Contract manufacturing dominated by service, while contract development is set ...
November 01, 2025
According to forecasts, the global active pharmaceutical ingredients CDMO market will grow from USD 127.45 billion in 2024 to USD 260.98 billion by 2034, with an expected CAGR of 7.43%. In 2024, Asia-Pacific led the global API market, while North America is set for strong CDMO growth. Traditional APIs and synthetic synthesis dominated, but antibody...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com